 present,
no clear conclusion can be drawn between hospital volume and outcomes after TEVAR. Importantly, even fewer
data are available to examine the role of individual clinician TEVAR volume and outcomes.

CONCLUSIONS
TEVAR is used to treat a myriad of aortic diseases.
Whereas there are no randomized, controlled trials
comparing open and endovascular DTA repair directly
and probably never will be, consensus documents, large
administrative data sets, and meta-analyses